Company profile
ZIMMER BIOMET HOLDINGS, INC.
NYSE:ZBHIndustrial Specialties
Clinical trials (5)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT02182843 | — | completed | 2014-03-01 | 2018-01-01 | Zimmer Biomet | Cellentra Viable Cell Bone Matrix (VCBM) Anterior Cervical Discectomy and Fusion Outcomes Study (VCBM/MaxAn) |
| NCT00758641 | phase4 | completed | 2009-09-01 | 2016-01-01 | Zimmer Biomet | Platelet Rich Plasma to Treat Plantar Fasciitis |
| NCT00757289 | — | completed | 2007-08-01 | 2008-01-01 | Zimmer Biomet | Platelet-rich-plasma Treating Tennis Elbow |
| NCT02262364 | phase1 | completed | 2014-11-01 | 2016-10-01 | Zimmer Biomet | Safety of NStride Autologous Protein Solution in the Treatment of Knee Osteoarthritis (PROGRESS I) |
| NCT00761423 | phase4 | completed | 2008-08-01 | 2009-02-01 | Zimmer Biomet | The Value of Platelet-Rich Plasma in Chronic Midportion Achilles Tendinopathy: a Double-blind Randomized Clinical Trial |
FDA applications (0)
No records yet.